These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 21045014)

  • 1. Inpatients are sicker than outpatients; finally it's evidence-based.
    Dickstein K
    Europace; 2010 Dec; 12(12):1662-3. PubMed ID: 21045014
    [No Abstract]   [Full Text] [Related]  

  • 2. Inpatient vs. elective outpatient cardiac resynchronization therapy device implantation and long-term clinical outcome.
    Ajijola OA; Macklin EA; Moore SA; McCarty D; Bischoff KE; Heist EK; Picard M; Ruskin JN; Dec GW; Singh JP
    Europace; 2010 Dec; 12(12):1745-9. PubMed ID: 20852289
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [ Upgrading of cardiac resynchronization therapy devices in patients with heart failure--uprising clinical problem. ].
    Przybylski A
    Kardiol Pol; 2010 Nov; 68(11):1242. PubMed ID: 21108201
    [No Abstract]   [Full Text] [Related]  

  • 4. A device to prevent heart failure is twice as effective in women.
    Harv Womens Health Watch; 2011 May; 18(9):7. PubMed ID: 21818875
    [No Abstract]   [Full Text] [Related]  

  • 5. Device therapy in the elderly heart failure patient: what is the evidence?
    Rich MW
    Expert Rev Cardiovasc Ther; 2010 Sep; 8(9):1203-5. PubMed ID: 20828340
    [No Abstract]   [Full Text] [Related]  

  • 6. Coronary sinus atresia complicating cardiac resynchronization therapy.
    Nakamura T; Otomo K; Kawai S; Igawa O
    J Cardiovasc Electrophysiol; 2010 Oct; 21(10):1178. PubMed ID: 20522151
    [No Abstract]   [Full Text] [Related]  

  • 7. Reducing operator radiation exposure during cardiac resynchronization therapy.
    Brambilla M; Occhetta E; Ronconi M; Plebani L; Carriero A; Marino P
    Europace; 2010 Dec; 12(12):1769-73. PubMed ID: 21097481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiac resynchronization therapy for treatment of heart failure.
    Ho JK; Mahajan A
    Anesth Analg; 2010 Dec; 111(6):1353-61. PubMed ID: 21059745
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and prognostic role of pressure-volume relationship in the identification of responders to cardiac resynchronization therapy.
    Ciampi Q; Pratali L; Citro R; Villari B; Picano E; Sicari R
    Am Heart J; 2010 Nov; 160(5):906-14. PubMed ID: 21095279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Utilization of defibrillators and resynchronization therapy at the time of evaluation at a heart failure and cardiac transplantation center.
    Sims DB; Garcia LI; Mignatti A; Colombo PC; Jones M; Uriel N; Mancini DM; Jorde UP
    Pacing Clin Electrophysiol; 2010 Aug; 33(8):988-93. PubMed ID: 20353413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In- and outpatients with noncompaction: differences in cardiac and neuromuscular co-morbidity.
    Stöllberger C; Blazek G; Winkler-Dworak M; Finsterer J
    Int J Cardiol; 2010 Apr; 140(1):108-11. PubMed ID: 19095319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiac resynchronisation therapy: evidence based benefits and patient selection.
    Albouaini K; Egred M; Rao A; Alahmar A; Wright DJ
    Eur J Intern Med; 2008 May; 19(3):165-72. PubMed ID: 18395159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Using cardiac resynchronization therapy diagnostics for monitoring heart failure patients.
    Adamson PB
    Heart Fail Clin; 2009 Apr; 5(2):249-60. PubMed ID: 19249693
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Applying evidence-based device care in cardiovascular patients: which patient with heart failure and what device?
    Cleland JG; Buga L; Ghosh J; Nasir M
    J R Coll Physicians Edinb; 2010 Sep; 40(3):229-39. PubMed ID: 21127768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New ESC heart failure guidelines with South African expert comment.
    Aalbers J
    Cardiovasc J Afr; 2012 Jun; 23(5):295-6. PubMed ID: 23077733
    [No Abstract]   [Full Text] [Related]  

  • 16. Prevalence and risk factors related to infections of cardiac resynchronization therapy devices.
    Romeyer-Bouchard C; Da Costa A; Dauphinot V; Messier M; Bisch L; Samuel B; Lafond P; Ricci P; Isaaz K
    Eur Heart J; 2010 Jan; 31(2):203-10. PubMed ID: 19875388
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Echocardiographic mapping of left ventricular resynchronization during cardiac resynchronization therapy procedures.
    Chan NY; Choy CC; Cheung KC; Lau CL; Lo YK; Chu PS; Yuen HC; Lau ST; Choi YC
    Chin Med J (Engl); 2010 Jul; 123(13):1645-51. PubMed ID: 20819622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. "Advantage of optimizing V-V timing in cardiac resynchronization therapy devices" by Dr. Duvall.
    Geng J; Zhu J
    Pacing Clin Electrophysiol; 2010 Oct; 33(10):1289-90; author reply 1290-1. PubMed ID: 20718923
    [No Abstract]   [Full Text] [Related]  

  • 19. Cardiac resynchronization therapy for chronic heart failure in China: guideline and practice.
    Hua W
    Chin Med J (Engl); 2010 Sep; 123(17):2293-4. PubMed ID: 21034536
    [No Abstract]   [Full Text] [Related]  

  • 20. Predicting and preventing heart failure rehospitalizations: is there a role for implantable device diagnostics?
    Dunlay SM; Gersh BJ
    Am J Cardiol; 2013 Jan; 111(1):85-7. PubMed ID: 23040587
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.